Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
North Carolina A&T State University Completes Science Building
North Carolina Agricultural and Technical State University will dedicate its new 74,100-sf science building on April 7, 2006. The $21.8-million facility will house the chemistry and psychology departments and is part of the College of Arts & Sciences.
Arizona Biomedical Collaborative Building Breaks Ground in Phoenix
Groundbreaking on the new 85,000-sf Arizona Biomedical Collaborative building (ABC) on the Phoenix Biomedical Campus was celebrated on March 16, 2006. Housing Arizona State University's Department of Biomedical Informatics and the University of Arizona's College of Medicine wet lab space for diabetes, cancer, and neurological research, the facility is the first public building dedicated to research in Phoenix.
UNC Chapel Hill Begins Second Phase of Genetic Medicine Building Construction
The University of North Carolina at Chapel Hill has initiated the second phase of construction on its 331,000-sf Genetic Medicine Building (GMB). The $120-million multidisciplinary research facility, comprised of seven stories plus a mechanical penthouse, has a deep footprint of approximately 40,000 sf of contiguous space. The GMB is designed around a central atrium that brings light into the entire building, even into the enclosed labs and offices through punched-out windows and open doors.
Temple University's School of Pharmacy Opens Drug Manufacturing Facility
Temple University's School of Pharmacy opened a 700-sf drug manufacturing facility in February of 2006. Located on the fourth floor of the pharmacy school building in north Philadelphia, the facility adheres to FDA cGMP requirements and features a sophisticated air-filtration system, a non-porous ceiling, and seamless flooring. The plant will manufacture capsules and tablets used in phase-I and phase-II clinical trials in batches of between 1,000 and 100,000 units.
Amgen Expands in South San Francisco
Biotech giant Amgen will expand its South San Francisco campus with the addition of 500,000 sf of R&D space over the next three years. The first 92,000-sf facility is under construction; a second 92,000-sf structure will break ground in spring of 2006. The two buildings will house up to 700 employees total. Amgen also has an option to occupy three new adjacent buildings, yet to be constructed, with footprints of 100,000 sf each.